Invention Grant
- Patent Title: ALA and salt formulation
-
Application No.: US16212667Application Date: 2018-12-06
-
Publication No.: US10993929B2Publication Date: 2021-05-04
- Inventor: William C. Zolentroff
- Applicant: MOLECULAR PRODUCT MANAGEMENT LLC
- Applicant Address: US NY New York
- Assignee: MOLECULAR PRODUCT MANAGEMENT LLC
- Current Assignee: MOLECULAR PRODUCT MANAGEMENT LLC
- Current Assignee Address: US NY New York
- Agency: Transformative Legal, LLC
- Agent Len Smith; Denise Brown
- Main IPC: A61K31/385
- IPC: A61K31/385 ; A61P15/08 ; A61P5/34 ; A61K9/00 ; A61K9/20 ; A61P25/02

Abstract:
The addition of a salt to an ALA formulation that is dissolved in the mouth unexpectedly significantly reduces the degree of burning or irritation from ALA exposure during administration. This invention is particularly useful for an oral dissolved form of administration due to the extended time of ALA exposure that is possible with such formulations. The salt-inclusive formulations of the invention can increase efficacy of the ALA administration, reduce negative side effects, or both.
Public/Granted literature
- US20190105300A1 ALA AND SALT FORMULATION Public/Granted day:2019-04-11
Information query